Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Paracetamol use during pregnancy - a call for precautionary action

Research output: Contribution to journalReviewResearchpeer-review

  1. Who would have thought - myokines two decades on

    Research output: Contribution to journalEditorialResearchpeer-review

  2. From conception to infancy - early risk factors for childhood obesity

    Research output: Contribution to journalReviewResearchpeer-review

  3. Physical activity and muscle-brain crosstalk

    Research output: Contribution to journalReviewResearchpeer-review

  4. Improving pregnancy outcomes in women with diabetes mellitus: modern management

    Research output: Contribution to journalReviewResearchpeer-review

  1. Comprehensive Evaluation of Blood Plasma and Serum Sample Preparations for HRMS-Based Chemical Exposomics: Overlaps and Specificities

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Endocrine Disrupting Chemicals and Risk of Testicular Cancer: A Systematic Review and Meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Poor social support and loneliness in chronic headache: Prevalence and effect modifiers

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Health-related quality of life in tension-type headache: a population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Paracetamol (N-acetyl-p-aminophenol (APAP), otherwise known as acetaminophen) is the active ingredient in more than 600 medications used to relieve mild to moderate pain and reduce fever. APAP is widely used by pregnant women as governmental agencies, including the FDA and EMA, have long considered APAP appropriate for use during pregnancy when used as directed. However, increasing experimental and epidemiological research suggests that prenatal exposure to APAP might alter fetal development, which could increase the risks of some neurodevelopmental, reproductive and urogenital disorders. Here we summarize this evidence and call for precautionary action through a focused research effort and by increasing awareness among health professionals and pregnant women. APAP is an important medication and alternatives for treatment of high fever and severe pain are limited. We recommend that pregnant women should be cautioned at the beginning of pregnancy to: forego APAP unless its use is medically indicated; consult with a physician or pharmacist if they are uncertain whether use is indicated and before using on a long-term basis; and minimize exposure by using the lowest effective dose for the shortest possible time. We suggest specific actions to implement these recommendations. This Consensus Statement reflects our concerns and is currently supported by 91 scientists, clinicians and public health professionals from across the globe.

Original languageEnglish
JournalNature reviews. Endocrinology
Volume17
Issue number12
Pages (from-to)757-766
Number of pages10
ISSN1759-5029
DOIs
Publication statusPublished - Dec 2021

Bibliographical note

© 2021. The Author(s).

ID: 67850509